OBI Pharma (ROCO:4174) 3-Year Revenue Growth Rate : -36.40% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma 3-Year Revenue Growth Rate?

OBI Pharma's Revenue per Share for the three months ended in Mar. 2024 was NT$0.04.

During the past 12 months, OBI Pharma's average Revenue per Share Growth Rate was 826.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was -36.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of OBI Pharma was 605.40% per year. The lowest was -62.10% per year. And the median was -10.20% per year.

Competitive Comparison of OBI Pharma's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, OBI Pharma's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OBI Pharma's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where OBI Pharma's 3-Year Revenue Growth Rate falls into.

OBI Pharma 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

OBI Pharma (ROCO:4174) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

OBI Pharma 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of OBI Pharma's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OBI Pharma (ROCO:4174) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3, Park Street, Room. 1907, 19th Floor, Nangang District, Taipei, TWN, 115

Website

https://www.obipharma.com

OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The Group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma (ROCO:4174) Headlines

No Headlines